FORMA FT4202-Hem-301 PRAISE PTV. An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE).
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
FORMA Therapeutics, Inc.
Start Date
April 6, 2021
End Date
March 30, 2024
Administered By
Medicine, Hematology
Awarded By
FORMA Therapeutics, Inc.
Start Date
April 6, 2021
End Date
March 30, 2024